Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies
about
sameAs
Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsPathophysiology of the antiphospholipid syndromeDomain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies.Vascular Pathophysiology in Hearing Disorders.Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinAnnexin A2 tetramer activates human and murine macrophages through TLR4.Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.Coherent somatic mutation in autoimmune disease.Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin.The prevalence of positive serum anticardiolipin antibodies and asymptomatic bacteriuria in women with recurrent abortions.Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.Differential regulation of proinflammatory mediators following LPS- and ATP-induced activation of monocytes from patients with antiphospholipid syndrome.Pathophysiology of the antiphospholipid antibody syndrome.Purified IgG from patients with obstetric but not IgG from non-obstetric antiphospholipid syndrome inhibit trophoblast invasion.Interaction of β2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.The Effects of NF-κB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-β2GPI in MouseAnti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.Oral inflammatory diseases and systemic inflammation: role of the macrophage.Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studiesBinding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43Infectious origin of the antiphospholipid syndrome.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Antiphospholipid antibodies: effects on trophoblast and endothelial cells.Pathogenic role of antiphospholipid antibodiesPlatelets and the antiphospholipid syndrome.Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.Annexin A2: biology and relevance to the antiphospholipid syndrome.Tissue factor in the antiphospholipid syndrome.Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway.The dual role of innate immunity in the antiphospholipid syndrome.Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies.
P2860
Q26998188-9C45F28F-ADEF-45C8-B92E-72CABEADBB49Q28267421-519B8F9C-2344-482A-90B1-DC85533AE4B7Q28291393-613C6BF8-A1DA-4AD1-AE26-55C8FB4457B6Q30422807-63A2AD86-F773-46AC-BACD-6DE220982FB0Q30427799-1F11191A-1288-4137-8FA8-CA47BD91F6E8Q33511345-C8E1E885-9DA5-437F-9690-DC3402C9FBFBQ33608764-26325198-C971-4F09-8D77-E0E3F779484AQ33788761-CF375B9C-2B32-4105-A13E-F60B34D1F8C7Q33837769-551E35D1-C53F-4208-99B4-F10FBC83DF77Q33967600-16F29F2E-2CD7-405D-B2D0-830D69230565Q34287356-A6C1C152-6A94-449B-8E02-8E3001B1CD80Q34364580-4E12E8A3-B6B9-4F63-BAE3-76F58A7342A9Q34401715-6C429D89-64B7-4B01-AB69-5F18859FD3BDQ34478786-51EE5CC1-15F9-4A1A-ACDE-362D6687823BQ34667153-0EC0E663-3BF8-4A0A-BAAF-8B612338BFF5Q34676688-9DAB13D1-8990-4206-B077-2C0B0A9A3710Q34869404-B1921CAD-C5F4-4A14-A52E-3B7FAEE83994Q35133146-36E95E31-9097-4E95-B844-37C245FE6BB6Q35309024-1125E84F-36D0-4A24-9F5A-47ECC1B194F0Q35535795-E902CBBD-5C3F-41E5-A577-E6DF58ADBB76Q35604834-D03DEC23-BA85-442A-94AE-7C828F7EC657Q35849691-87344CD8-AD6F-4EBF-8C18-3E77714412BCQ35874202-4A393C23-7812-410A-9F5A-1922F2DD16EFQ35909733-C10D2DEA-20B3-4124-A376-CB3A96A4A8A5Q35953541-40D47B49-0534-49D1-A5A9-566EB254D738Q35963446-2965F74F-FDC2-442D-BA5E-5ED3D83FF18FQ36013878-1C48FBED-A53E-4B48-86F7-1BF57E02A511Q36225236-B65FAFC7-B9D5-4BEE-9F06-40F121C16DDAQ36339540-2175C555-E0F7-4FCB-938F-6FDD04E03675Q36799474-1C2F51DF-4EED-4496-B13A-2B0350A470EBQ36881604-694171D3-DA74-4C0D-BE3C-46C118707938Q37168017-40499E0D-456F-422C-952A-A6082B5EE42EQ37283013-DF7D687C-3C01-4F3A-82C9-3DE0E90E9A70Q37283036-1F078FD8-8772-4F4C-9C06-3F1346F73DB7Q37283042-F5FC8B46-F445-4316-BD55-9A1DCE1D165CQ37283046-D6E3807D-44B4-4B0F-A012-6D0BAFFABFF1Q37349421-97B4FEE6-FFD4-4E4D-A14C-66A081E8EA44Q37409260-2616888F-7978-4241-8E53-CFE226460623Q37721589-757E6834-062A-41E7-B137-2EEA3DEACCC4Q37721592-7ACD7635-7C2A-45A2-A3FD-7553DD764E65
P2860
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@ast
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@en
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@nl
type
label
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@ast
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@en
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@nl
prefLabel
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@ast
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@en
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@nl
P2093
P50
P1433
P1476
Role of the MyD88 transduction ...... by antiphospholipid antibodies
@en
P2093
Cinzia Testoni
Daniela Bosisio
Elena Raschi
P304
P356
10.1182/BLOOD-2002-08-2349
P407
P577
2003-05-01T00:00:00Z